Clinical Trial Update: Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 trial evaluating pancrelipase in metastatic pancreatic ductal adenocarcinoma. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Pancrelipase (pancrelipase)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING